Advisory Committee on Immunization Practices (ACIP), 40701 [2016-14787]
Download as PDF
40701
Federal Register / Vol. 81, No. 120 / Wednesday, June 22, 2016 / Notices
pathogens. Data elements for hypothesis
generation must be developed and
agreed upon for each investigation. This
process can take several days to weeks
and may cause interviews to occur long
after a person becomes ill.
CDC requests a revision to this project
to collect standardized information,
called the Standardized National
Hypothesis-Generating Questionnaire,
from individuals who have become ill
during a multistate foodborne disease
event. Since the questionnaire is
designed to be administered by public
health officials as part of multistate
hypothesis-generating interview
activities, this questionnaire is not
expected to entail significant burden to
respondents.
The Standardized National
Hypothesis-Generating Core Elements
Project was established with the goal to
define a core set of data elements to be
used for hypothesis generation during
multistate foodborne investigations.
These elements represent the minimum
set of information that should be
available for all outbreak-associated
cases identified during hypothesis
generation. The core elements would
ensure that similar exposures would be
vehicles out of commerce. In almost all
instances, the SNHGQ or iterations of
the SNHGQ have been instrumental in
the successful investigation of these
outbreaks. The questionnaire has
allowed investigators to more efficiently
and effectively interview ill persons as
they are identified. Because these
exposures are captured in a common,
standard format, we have been able to
share and analyze data rapidly across
jurisdictional lines. Faster interview
response and analysis times have
allowed for more rapid epidemiologic
investigation and quicker regulatory
action, thus helping to prevent
thousands of additional illnesses from
occurring and spurring industry to
adopt and implement new food safety
measures in an effort to prevent future
outbreaks.
The total estimated annualized
burden for the Standardized National
Generating Questionnaire is 3,000 hours
(approximately 4,000 individuals
identified during the hypothesisgenerating phase of outbreak
investigations with 45 minutes/
response).
There are no costs to respondents
other than their time.
ascertained across many jurisdictions,
allowing for rapid pooling of data to
improve the timeliness of hypothesisgenerating analyses and shorten the
time to pinpoint how and where
contamination events occur.
The Standardized National
Hypothesis Generating Questionnaire
was designed as a data collection tool
for the core elements, to be used when
a multistate cluster of enteric disease
infections is identified. The
questionnaire is designed to be
administered over the phone by public
health officials to collect core elements
data from case-patients or their proxies.
Both the content of the questionnaire
(the core elements) and the format were
developed through a series of working
groups comprised of local, state, and
federal public health partners.
Since implementation of the SNHGQ
in 2013, ORPB has investigated over 700
multistate foodborne and enteric
clusters of infection involving over
26,000 ill people. Of which, an outbreak
vehicle has been identified in 200 of
these investigations. These outbreaks
have led to over 50 recalls and countless
regulatory actions that have removed
millions of pounds of contaminated
ESTIMATED ANNUALIZED BURDEN HOURS
Number of
respondents
Number of
responses per
respondent
Average
burden per
response
(in hrs)
Total burden
(in hrs)
Type of respondents
Form name
Individuals ..................................
Standardized National Hypothesis Generating Questionnaire (Core Elements).
4,000
1
45/60
3,000
Total ....................................
.................................................................
........................
........................
........................
3,000
Leroy A. Richardson,
Chief, Information Collection Review Office,
Office of Scientific Integrity, Office of the
Associate Director for Science, Office of the
Director, Centers for Disease Control and
Prevention.
[FR Doc. 2016–14727 Filed 6–21–16; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
mstockstill on DSK3G9T082PROD with NOTICES
Centers for Disease Control and
Prevention
Advisory Committee on Immunization
Practices (ACIP)
Amendment: A notice of this meeting
was published in the Federal Register
on May 24, 2016, Volume 81, Number
100, Pages 32754–32755. The original
notice is amended to include Matters for
Discussion as follows:
VerDate Sep<11>2014
20:02 Jun 21, 2016
Jkt 238001
Matters for Discussion: The agenda
will include discussions on
meningococcal vaccines; human
papillomavirus vaccines; influenza;
cholera vaccine; hepatitis vaccines;
safety of maternal Tdap vaccination;
Respiratory Syncytial Virus (RSV) and
vaccine supply. A recommendation vote
is scheduled for meningococcal
vaccines, influenza vaccine, and cholera
vaccine. A VFC vote is scheduled for
meningococcal vaccines, and influenza.
Agenda items are subject to change as
priorities dictate.
Contact Person for More Information:
Stephanie Thomas, National Center for
Immunization and Respiratory Diseases,
CDC, 1600 Clifton Road NE., MS–A27,
Atlanta, Georgia 30329, telephone 404/
639–8836; Email ACIP@CDC.GOV.
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
PO 00000
Frm 00049
Fmt 4703
Sfmt 9990
meetings and other committee
management activities for both the
Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Elaine L. Baker,
Director, Management Analysis and Services
Office Centers for Disease Control and
Prevention.
[FR Doc. 2016–14787 Filed 6–21–16; 8:45 am]
BILLING CODE 4160–18–P
E:\FR\FM\22JNN1.SGM
22JNN1
Agencies
[Federal Register Volume 81, Number 120 (Wednesday, June 22, 2016)]
[Notices]
[Page 40701]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2016-14787]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Advisory Committee on Immunization Practices (ACIP)
Amendment: A notice of this meeting was published in the Federal
Register on May 24, 2016, Volume 81, Number 100, Pages 32754-32755. The
original notice is amended to include Matters for Discussion as
follows:
Matters for Discussion: The agenda will include discussions on
meningococcal vaccines; human papillomavirus vaccines; influenza;
cholera vaccine; hepatitis vaccines; safety of maternal Tdap
vaccination; Respiratory Syncytial Virus (RSV) and vaccine supply. A
recommendation vote is scheduled for meningococcal vaccines, influenza
vaccine, and cholera vaccine. A VFC vote is scheduled for meningococcal
vaccines, and influenza.
Agenda items are subject to change as priorities dictate.
Contact Person for More Information: Stephanie Thomas, National
Center for Immunization and Respiratory Diseases, CDC, 1600 Clifton
Road NE., MS-A27, Atlanta, Georgia 30329, telephone 404/639-8836; Email
ACIP@CDC.GOV.
The Director, Management Analysis and Services Office, has been
delegated the authority to sign Federal Register notices pertaining to
announcements of meetings and other committee management activities for
both the Centers for Disease Control and Prevention and the Agency for
Toxic Substances and Disease Registry.
Elaine L. Baker,
Director, Management Analysis and Services Office Centers for Disease
Control and Prevention.
[FR Doc. 2016-14787 Filed 6-21-16; 8:45 am]
BILLING CODE 4160-18-P